Preliminary data on the CoronaVac—a COVID-19 vaccination manufactured by the Beijing-based biopharmaceutical company Sinovac—demonstrated only about 50% efficacy in preventing mild and severe COVID-19 illness in a Brazilian clinical trial.…

Register today for the free webinar.

This information is from the article Cutting the Red Tape by Jane Koppelman. To read the article, click here.

Tedros Adhanom Ghebreyesu, PhD—director-general of the World Health Organization (WHO)—criticized vaccine manufacturers for putting profits above ethics when it comes to equitably distributing COVID-19 immunizations. In an executive board…

Musculoskeletal disorders (MSDs) are a leading cause of workplace injury, decreased production, and early retirement among oral health professionals. Clinicians in dentistry experience MSDs at higher rates in the back, neck, and shoulders…

With more than 2 million deaths attributed to COVID-19 across the world, public health officials are desperate to reduce the spread of the novel coronavirus while increasing vaccination rates. Some health experts have suggested that wearing…

As the United States struggles to get as many people vaccinated as quickly as possible, states have begun adjusting their priority policies. In New Jersey, all those age 65 and older and individuals between the ages of 16 and 64 with…

Two more contagious strains of the novel coronavirus have been identified in the United Kingdom and South Africa, but the United States has a chance to reduce their transmission here. While the strains (B117 from the UK, and 501Y.V2 or…

Register today for HuFriedyGroup's Essential: The Best in Practice Virtual Summit, scheduled for Friday, January 22. 

The U.S. Department of Health and Human Services (HHS) announced the Centers for Disease Control and Prevention (CDC) will provide more than $22 billion in funding to states, localities, and territories in support of the nation’s response…